With people of minority background and those with obesity and diabetes most at risk for severe cases of COVID-19, the National Institute of Diabetes and Digestive and Kidney Diseases is leading in the research behind why that is. Director Dr. Griffin Rodgers, who contributed to the first effective therapy for sickle cell anemia, updates HealthCast on the institute’s work to lessen the effects of COVID-19 on its research community, as well as other top research and data initiatives at the institution.
HealthCast
Season 2
Episode 17
21m listen
How One NIH Institute is Combating COVID-19 and Health Disparities
NIDDK Director Dr. Griffin Rodgers talks COVID-19, disparities in health, and top priorities at the institute.
-
Dr. Griffin Rodgers Director NIDDK
Related Content
-
Cyber Resilience and Recovery Amid Evolving Cyber Threats
Data durability is a key aspect of NIST’s cybersecurity framework for public and private organizations.
21m listen -
How Tech Enables Environmental Justice at EPA
The agency wants to eliminate bias and establish new tech standards to reduce greenhouse gas emissions.
39m listen -
Building Better Data Governance Across FDA
The agency is using emerging technology to tackle its data challenges.
19m listen -
Coast Guard Poised for Growth in Cyber
The service’s prevention policy chief discusses his priorities for combatting cyber incidents that could have global impacts.
23m listen